References
- Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236. doi:https://doi.org/10.1159/000078612.
- de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011 Nov;30(6):452–470. doi:https://doi.org/10.1016/j.preteyeres.2011.06.005.
- Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013 Sep-Oct;23(5):705–717. doi:https://doi.org/10.5301/ejo.5000278.
- Rosenbaum JT, Bodaghi B, Couto C, et al. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review. Semin Arthritis Rheum. 2019 Dec;49(3):438–445. doi:https://doi.org/10.1016/j.semarthrit.2019.06.004.
- Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844–848. doi:https://doi.org/10.1136/bjo.80.9.844.
- Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332–336. doi:https://doi.org/10.1136/bjo.80.4.332.
- Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001;80(4):263–270. doi:https://doi.org/10.1097/00005792-200107000-00005.
- Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162. doi:https://doi.org/10.1136/bjo.2003.037226.
- Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol. 2010;150(4):534–542. doi:https://doi.org/10.1016/j.ajo.2010.04.031.
- Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121(12):2387–2392. doi:https://doi.org/10.1016/j.ophtha.2014.07.007.
- Dick AD, Tundia N, Sorg R, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology. 2016;123(3):655–662. doi:https://doi.org/10.1016/j.ophtha.2015.10.028.
- Niederer RL, Sharief L, Bar A, Lightman SL, Tomkins-Netzer O. Predictors of long-term visual outcome in intermediate uveitis. Ophthalmology. 2017;124(3):393–398. doi:https://doi.org/10.1016/j.ophtha.2016.11.013.
- Cann M, Ramanan AV, Crawford A, et al. Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol Online J. 2018 Aug 6;16(1):51. doi:https://doi.org/10.1186/s12969-018-0266-5.
- Al-Ani HH, Sims JL, Tomkins-Netzer O, Lightman S, Niederer RL. Vision loss in anterior uveitis. Br J Ophthalmol. 2020;104(12):1652–1657. doi:https://doi.org/10.1136/bjophthalmol-2019-315551.
- Oh BL, Lee JS, Lee EY, Lee HY, Yu HG. Incidence and risk factors for blindness in uveitis: a nationwide cohort study from 2002 to 2013. Ocul Immunol Inflamm. 2021;29(6):1041–1045. doi:https://doi.org/10.1080/09273948.2020.1746352.
- Pistilli M, Joffe MM, Gangaputra SS, et al. Systemic immunosuppressive therapy for eye diseases (SITE) research group. Visual acuity outcome over time in non-infectious uveitis. Ocul Immunol Inflamm. 2021;29(6):1065–1072. doi:https://doi.org/10.1080/09273948.2019.1687733.
- Pistilli M, Gangaputra SS, Pujari SS, et al. Contemporaneous risk factors for visual acuity in non-infectious uveitis. Ocul Immunol Inflamm. 2021;29(6):1057–1064. doi:https://doi.org/10.1080/09273948.2020.1828493.
- Jin Y, Lin D, Dai ML, et al. Economic hardship, ocular complications, and poor self-reported visual function are predictors of mental problems in patients with uveitis. Ocul Immunol Inflamm. 2021;29(6):1046–1056. doi:https://doi.org/10.1080/09273948.2020.1770297.